Smaller sized doses for perioral treatment than for higher facial purposes are applied since the oral musculature responds a lot more strongly to the identical BTX-A dosing. Only one preparing of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA acceptance lies in treatments of cervical dystonia.Breastfeeding: The m